The North America Home Infusion Therapy Market size was valued at USD 17.74 billion in 2025 and is projected to grow from USD 19.14 billion in 2026 to reach USD 35.17 billion by 2034, growing at a CAGR of 7.9% during the forecast period 2026–2034.
An alternative to taking medication by mouth is infusion therapy, which is how the term is defined. The infusion process involves monitoring the administration of medication with the assistance of a sterile catheter inserted into a vein. Home infusion therapy refers to giving an individual medication or biologicals through an intravenous or subcutaneous route while they live in their residence. The medication (such as antivirals or immune globulin, for example), the necessary piece of medical equipment (such as a pump), and the necessary medical supplies
are required to carry out home infusion (for example, tubing and catheters). In a similar vein, nursing services must educate and train both the patient and the caregivers administering the infusion medications in the patient's home. Home infusion treatment frequently requires a significant contribution from visiting nurses. Typically, nurses will instruct the patient or the caregiver on how to self-administer the medication, educate the patient about the potential adverse effects of the treatment and the aims of therapy, and visit the patient occasionally to evaluate the infusion site and change the dressing. In most cases, the procedure of home infusion needs coordination among several different parties. These parties can include patients, physicians, hospital discharge planners, health plans, home infusion pharmacies, and, if necessary, home health organisations.
Download a Free Sample To learn more about this report,
Virtual Clinical Support for Home Infusion
The North America Home Infusion Therapy Market analysis shows that virtual clinical support is becoming more relevant as providers manage complex infusion therapies outside hospital settings. The transition toward remote monitoring, telephonic communication, and digital clinical coordination allows nurses and pharmacists to support patients between in-person visits, with CMS recognizing remote monitoring and other monitoring services as components of covered home infusion therapy and 2025 Medicare payment rates covering home infusion services. This shift strengthens continuous patient support and contributes to the market share of home-based infusion services.
Alternate-Site Infusion and Home Care Integration
The North America Home Infusion Therapy Market analysis shows that providers are integrating home infusion with ambulatory infusion suites and home-health services to match treatment needs with appropriate care settings. The transition toward coordinated alternate-site care allows patients to receive therapy initiation, monitoring, catheter care, and self-administration training across home and outpatient settings, while the 2025 NHIA conference brought together nearly 1,600 professionals and 150 companies from the home and alternate-site infusion sector. This shift expands flexible care pathways and supports broader adoption of infusion therapy outside hospitals.
Development of Self-Administration Infusion Devices and Preference for Lower-Cost Care Settings Drive Market
Self-administration infusion devices allow suitable patients to receive prescribed therapies with less reliance on continuous professional assistance.Portable pumps, prefilled systems, and wearable infusion devices improve convenience and can support treatment outside hospital settings.Patients and home infusion providers therefore require reliable devices for therapies such as antibiotics, biologics, and immunoglobulin treatments.For example, wearable infusion pumps can deliver medication over several hours while patients continue routine activities at home.Wider availability of user-friendly devices supports home infusion adoption and creates additional equipment and service requirements for providers.
Lower treatment costs outside hospitals can encourage healthcare providers and payers to shift suitable infusion patients toward home-based care.Home infusion services can reduce the need for inpatient beds and hospital-based resources when patients can safely receive prescribed therapies at home.Healthcare providers, insurers, and home infusion companies therefore have greater scope to support eligible patients through home-based treatment programs.For example, outpatient antibiotic infusion can allow clinically stable patients to continue treatment at home instead of occupying hospital beds.Greater use of cost-efficient care settings supports patient volumes for home infusion providers and strengthens the need for related nursing, pharmacy, and equipment services.
High Costs of Specialized Infusion Devices and Regulatory and Compliance Requirements for Home-Based Care Restrain Market Expansion
High costs of specialized infusion pumps, catheters, and related equipment increase the investment required for home infusion providers and patients. Expensive devices can create financial pressure, particularly for patients with limited coverage and providers serving cost-sensitive populations. These cost barriers can restrict equipment adoption and limit the expansion of home infusion services.
Regulatory and compliance requirements involve strict standards for medication handling, patient monitoring, infection control, and clinical documentation in home settings.Compliance activities can increase administrative workloads and require additional training, quality controls, and monitoring resources for providers.These requirements can raise operating costs and slow the expansion of home-based infusion programs.
Home infusion providers, healthcare systems, remote-monitoring companies, and specialty pharmacies are key beneficiaries, as monitoring helps identify adverse reactions and other complications during home treatment. Remote monitoring creates revenue through connected devices, monitoring subscriptions, clinical support, and data-management services. Companies such as Biofourmis and Philips provide remote patient-monitoring technologies that can support home-based care.
Home infusion providers, specialty pharmacies, immunoglobulin manufacturers, and healthcare organizations are key beneficiaries, as immunoglobulin therapies often require recurring treatment and patient support. Home-based services create revenue through medication administration, nursing services, infusion supplies, and recurring care programs. Companies such as Option Care Health and CVS Health provide home infusion services that include immunoglobulin therapy.
High Travel and Coordination Workload and Complex Therapy Coordination Hinders Growth
Home infusion providers must account for nurse travel, pre-visit coordination, documentation, and communication with pharmacies and prescribers. These activities reduce productive clinical time and make expansion into geographically dispersed patient populations more difficult. A 2026 NHIA study found mean round-trip nurse travel time of 1.23 hours during therapy initiation.
Home infusion involves coordination among prescribers, pharmacies, nurses, patients, and caregivers, particularly during therapy initiation and transitions from hospitals.Coordination failures can delay starts and increase administrative workload, limiting provider capacity. A 2026 NHIA study found substantial nurse time was spent on care coordination, documentation, and telephone communication before and during initial visits.
Products include infusion devices, administration equipment, and related consumables used to support medication and fluid delivery in home settings. Services cover pharmacy support, nursing care, clinical monitoring, logistics, training, and care coordination required for home-based infusion therapy.
Request Customizationto receive a tailored report.
Infusion Pumps provide controlled delivery of medications, fluids, and nutrition and support accurate administration during home-based treatment. Intravenous Sets connect infusion devices with the patient and support the controlled delivery of prescribed therapies. IV Cannulas provide vascular access for administering intravenous medications and fluids in home care settings.Needleless Connectors support safer access to intravenous lines while helping reduce needle-related injuries and contamination risks.
Anti-Infective therapies support home-based treatment for infections that require prolonged or repeated intravenous medication administration. Endocrinology applications include infusion-based therapies used for patients requiring ongoing management of endocrine and metabolic conditions. Hydration Therapy provides fluids to patients who require supplemental hydration outside hospital settings. Chemotherapy supports selected cancer treatments that can be safely administered and monitored in the home environment.Enteral Nutrition provides nutritional support through feeding systems for patients who cannot obtain adequate nutrition through normal oral intake. Parenteral Nutrition delivers nutrients intravenously to patients whose gastrointestinal systems cannot adequately support nutritional requirements.Specialty Pharmaceuticals include complex and high-value therapies that require specialized administration, monitoring, patient education, and clinical support.
Speak to an Analystto discuss market opportunities.
The North America Home Infusion Therapy Market accounted for the largest regional share of 42.6% in 2025. The region benefits from established healthcare infrastructure, a large chronic disease patient population, and broader adoption of home-based care. Increasing preference for convenient treatment settings and advances in infusion devices further support market growth.
The U.S. Census Bureau projects that the population aged 65 and older will reach about 73.9 million by 2030, representing approximately 21% of the U.S. population, supporting longer-term demand for healthcare services, including home-based treatment and infusion care. Canada projects that the population aged 85 and older will continue to increase rapidly, particularly between 2031 and 2050, as baby-boom cohorts enter this age group where healthcare and health-service needs are higher, supporting the long-term need for home-based care options.
The North America Home Infusion Therapy Market is highly fragmented, with the market ecosystem comprising national home infusion providers, specialty pharmacies, integrated healthcare companies, hospital-affiliated infusion services, ambulatory infusion centers, and regional and local providers. The leading players in the North America Home Infusion Therapy Market include B. Braun Melsungen, Baxter International, Caesarea Medical Electronics Ltd., CareFusion, and Fresenius Kabi; B. Braun reported €9.396 billion in 2025 group sales, Baxter operates across infusion and connected-care technologies, Caesarea Medical Electronics specializes in infusion and ambulatory infusion pumps, CareFusion became part of Baxter through its 2015 acquisition, and Fresenius Kabi reported €8.612 billion in 2025 revenue, while a verified cumulative North America home infusion therapy market share for these five companies is not publicly disclosed by company filings or other non-market-research sources, so a defensible cumulative percentage cannot be assigned as market share.
Established players compete mainly through clinical expertise, therapy breadth, payer and pharmaceutical relationships, geographic coverage, quality of care, patient outcomes, care coordination, pricing, and service reliability, while the market ecosystem includes emerging and regional players that compete through personalized care, localized referral networks, flexible service models, specialized therapies, responsive nursing support, and cost-efficient delivery. The presence of national providers alongside numerous regional and local companies creates a competitive environment where service quality, clinical support, accessibility, and patient-centered care remain key differentiation factors.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Adiponectin Testing Market Size, Forecast, Demand, Opportunities, 2034
Antigen Skin Test Market Size, Forecast, Demand, Opportunities, 2034
Ultrasound Devices Market Size, Share, Growth, Analysis, 2034
Electrophysiology Market Size, Forecast, Opportunities, 2034
Blood Glucose Monitoring Devices Market Size, Forecast, Demand, Opportunities, 2034
We are featured on:
sales@straitsresearch.com